95 related articles for article (PubMed ID: 11104938)
1. Comparison of high dose buprenorphine treatments of opiate dependent outpatients in four healthcare networks.
De Ducla M; Gagnon A; Mucchielli A; Robinet S; Vellay A
Ann Med Interne (Paris); 2000 Oct; 151 Suppl B():B9-15. PubMed ID: 11104938
[TBL] [Abstract][Full Text] [Related]
2. [Follow-up of opioid addicts treated with high-dose buprenorphine in a health care network. National retrospective study. Experience of French general physicians].
De Ducla M; Gagnon A; Mucchielli A; Robinet S; Vellay A
Ann Med Interne (Paris); 2000 Apr; 151 Suppl A():A27-32. PubMed ID: 10855374
[TBL] [Abstract][Full Text] [Related]
3. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
4. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
5. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
6. [High-dose buprenorphine prescription in southern France from 1999 to 2001].
Mancini J; Thirion X; Masut A; Ronflé E; Coudert C; Pradel V; Frauger E; Micallef J
Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S7-14. PubMed ID: 12910029
[TBL] [Abstract][Full Text] [Related]
7. Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results.
Lavignasse P; Lowenstein W; Batel P; Constant MV; Jourdain JJ; Kopp P; Reynaud-Maurupt C; Riff B; Videau B; Mucchielli A
Ann Med Interne (Paris); 2002 May; 153(3 Suppl):1S20-6. PubMed ID: 12218879
[TBL] [Abstract][Full Text] [Related]
8. Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.
Soeffing JM; Martin LD; Fingerhood MI; Jasinski DR; Rastegar DA
J Subst Abuse Treat; 2009 Dec; 37(4):426-30. PubMed ID: 19553061
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients.
Poirier MF; Laqueille X; Jalfre V; Willard D; Bourdel MC; Fermanian J; Olié JP
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):267-72. PubMed ID: 14751421
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine replacement therapy: a confirmed benefit.
Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
[TBL] [Abstract][Full Text] [Related]
12. Subjective effects of additional doses of buprenorphine in patients on buprenorphine maintenance.
Singhal A; Tripathi BM; Pal HR; Jena R; Jain R
Addict Behav; 2007 Feb; 32(2):320-31. PubMed ID: 16814937
[TBL] [Abstract][Full Text] [Related]
13. Preference for buprenorphine/naloxone and buprenorphine among patients receiving buprenorphine maintenance therapy in France: a prospective, multicenter study.
Daulouède JP; Caer Y; Galland P; Villeger P; Brunelle E; Bachellier J; Piquet JM; Harbonnier J; Leglise Y; Courty P
J Subst Abuse Treat; 2010 Jan; 38(1):83-9. PubMed ID: 19800758
[TBL] [Abstract][Full Text] [Related]
14. Buprenorphine and naloxone interactions in opiate-dependent volunteers.
Mendelson J; Jones RT; Fernandez I; Welm S; Melby AK; Baggott MJ
Clin Pharmacol Ther; 1996 Jul; 60(1):105-14. PubMed ID: 8689806
[TBL] [Abstract][Full Text] [Related]
15. Abstinence-orientated buprenorphine replacement therapy for young adults in out-patient counselling.
Kornør H; Waal H; Ali RL
Drug Alcohol Rev; 2006 Mar; 25(2):123-30. PubMed ID: 16627301
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic response in outpatient opioid substitution treatment].
Barisić V; Barisić Z
Acta Med Croatica; 2009 Oct; 63(4):279-83. PubMed ID: 20034328
[TBL] [Abstract][Full Text] [Related]
17. Buprenorphine + naloxone: new combination. Opiate dependence: no proof of reduced risk of self-administered injection.
Prescrire Int; 2007 Dec; 16(92):232-5. PubMed ID: 18087797
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy under high-dose buprenorphine.
Simmat-Durand L; Lejeune C; Gourarier L;
Eur J Obstet Gynecol Reprod Biol; 2009 Feb; 142(2):119-23. PubMed ID: 19058904
[TBL] [Abstract][Full Text] [Related]
19. Comparison of buprenorphine and methadone in the treatment of opiate withdrawal: possible advantages of buprenorphine for the treatment of opiate-benzodiazepine codependent patients?
Reed LJ; Glasper A; de Wet CJ; Bearn J; Gossop M
J Clin Psychopharmacol; 2007 Apr; 27(2):188-92. PubMed ID: 17414244
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine treatment outcome in dually diagnosed heroin dependent patients: A retrospective study.
Gerra G; Leonardi C; D'Amore A; Strepparola G; Fagetti R; Assi C; Zaimovic A; Lucchini A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):265-72. PubMed ID: 16309810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]